|  | HR (95% CI) | P |
---|---|---|---|
Anthracycline-treatment | TIMP-1 low vs. all untreated | 0.71 (0.42-1.19) | 0.19 |
 | TIMP-1 high vs. all untreated | 0.97 (0.60-1.57) | 0.90 |
CMF-treatment | TIMP-1 low vs. all untreated | 0.48 (0.33-0.69) | <0.001 |
 | TIMP-1 high vs. all untreated | 0.57 (0.41-0.81) | 0.001 |
Age | 41-55 years vs. ≤ 40 years | 0.63 (0.49-0.81) | <0.001 |
Tumor size | Stage 2 (> 2 cm) vs. stage 1 (≤ 2 cm) | 1.80 (1.33-2.45) | <0.001 |
 | Stage 3 (>5 cm or chest wall/skin involvement) vs. stage 1 (≤ 2 cm) | 1.86 (1.26-2.74) |  |
Grade | Unknown vs. poor | 0.83 (0.61-1.11) | 0.08 |
 | Well/moderate vs. poor | 0.69 (0.49-0.98) |  |